Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay.
- DOI
- 10.1016/j.ijbiomac.2026.155194
- Published
- 2026 Nov 8
- Container
- International journal of biological macromolecules
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijbiomac.2026.155194,
title = {Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay.},
author = {Quadir SS and Tonge L and Ross K and Swadi R and Joshi G and Saleem I},
year = {2026},
journal = {International journal of biological macromolecules},
doi = {10.1016/j.ijbiomac.2026.155194},
url = {https://doi.org/10.1016/j.ijbiomac.2026.155194}
}RIS
TY - JOUR TI - Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay. AU - Quadir SS AU - Tonge L AU - Ross K AU - Swadi R AU - Joshi G AU - Saleem I PY - 2026 JO - International journal of biological macromolecules DO - 10.1016/j.ijbiomac.2026.155194 UR - https://doi.org/10.1016/j.ijbiomac.2026.155194 ER -
APA
SS, Q., L, T., K, R., R, S., G, J., & I, S. (2026). Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay.. International journal of biological macromolecules. https://doi.org/10.1016/j.ijbiomac.2026.155194
Source records
- pubmed · retrieved 2026-11-10T13:55:43.149Z